Build A Bear Workshop Inc vs BioNano Genomics Inc — how do they compare? Build A Bear Workshop Inc trades at $36.88 (market cap $461.88M), while BioNano Genomics Inc trades at $1.17 (market cap $13.66M). The key difference: Build A Bear Workshop Inc is far larger — about 33.8× BioNano Genomics Inc's market cap, and Build A Bear Workshop Inc pays a 2.5% dividend while BioNano Genomics Inc pays none. Which is the better fit depends on your goals.
| BBW | BNGO | |
|---|---|---|
Market Cap | $461.88M | $13.66M |
Sector | Consumer Cyclical | Health |
52-Week High | $75.85 | $4.92 |
52-Week Low | $29.84 | $1.06 |
Enterprise Value | $561.32M | $16.26M |
Dividend Yield | 2.5% | — |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
BNGO trades at $1.16 with a bullish technical signal supported by moving averages. The company shows improving financial trends with narrowing losses and consistent earnings beats, though it remains unprofitable with negative margins. Recent news highlights operational progress including debt retirement and scientific publications. Valuation ratios appear attractive with P/S of 0.31 and P/B of 0.36.
The outlook remains speculative given persistent losses, but improving cash flow trends and analyst optimism provide catalysts. Key risks include ongoing negative profitability and competitive pressures in genomics. With 57% analyst buy ratings and bullish technical momentum, the stock offers high-risk growth potential for investors comfortable with biotech volatility.
Trailing returns across standard periods
Build-A-Bear is a global retailer specializing in customizable stuffed animals. It offers an interactive make-your-own experience where customers choose, stuff, and dress their furry friends in-store or online.
Read more on BBW →Bionano Genomics Inc is a life sciences instrumentation company in the genome analysis space. It is engaged in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes.
Read more on BNGO →